Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
Story Views
Now:
Last hour:
Last 24 hours:
Total:

THE NEXT BIG TRADE IDEA™: $SWC $10.68 - STILLWATER MINING - PALLADIUM

% of readers think this story is Fact. Add your two cents.



LONG/SHORT EQUITY TRADING:  
WHERE TECHNICALS MEET FUNDAMENTALS

$10.00 Per Edition  http://www.tinyurl.com/tnbti

THE NEXT BIG TRADE IDEA™

A JOHN CHALEKSON NEWSLETTER

$SWC

TNBTI 7/8/13

STILLWATER MINING – PALLADIUM

$SWC STILLWATER MINING $10.68 — BUY
PALLADIUM HAS HELD UP MUCH BETTER THAN THE PRICE OF GOLD. EVEN WITH THE DISASTER IN THE SILVER AND GOLD MARKETS, PALLADIUM HAS MANAGED TO STILL BE POSITIVE FOR THE YEAR AND SHOWING A LOT OF RELATIVE STRENGTH AGAINST THE OTHER METALS.

CHART:

HOW MUCH MORE RARE IS PALLADIUM THAN GOLD AS IT EXISTS ON THE EARTH?  A. 10 TIMES  B.20 TIMES  C. 30 TIMES ? IF ITS THAT RARE AND IS CONSUMED BY INDUSTRY, WHY ISN’T THE PRICE MUCH HIGHER THAN GOLD? LIKE SAY, $24,400 PER OUNCE?  ITS CURRENTLY AROUND $650 AN OUNCE.

FROM INVESTOPEDIA:
Palladium is one of the rarest metals on earth, about 15 times more rare than platinum and 30 times more rare than gold. Belonging to the platinum group of metals, around 80% of the world’s palladium production comes from two countries: Russia and South Africa. In fact, Russia alone accounts for roughly half of the world’s production, which is estimated to be 200,000 ounces per year. This can create cause for concern as any decrease in exports from these countries can contribute to volatility in palladium prices. 

In comparison to platinum, palladium shares similar chemical properties but is less dense and has a lower melting point. 

WHAT ARE THE FUTURE APPLICATIONS OF PALLADIUM? CAN IT BE USED FOR (L.E.N.R.) LOW ENERGY NUCLEAR REACTIONS? WILL THIS BE COMMERCIALLY POSSIBLE AT SOME POINT IN THE FUTURE?

WHAT IS KNOWN IS THE COMPANY’S BALANCE SHEET. 

Key Statistics Get Key Statistics for: 
Data provided by Capital IQ, except where noted.
Valuation Measures  
Market Cap (intraday)5: 1.26B
Enterprise Value (Jul 7, 2013)3: 1.11B
Trailing P/E (ttm, intraday): 20.70
Forward P/E (fye Dec 31, 2014)1: 16.95
PEG Ratio (5 yr expected)1: 3.47
Price/Sales (ttm): 1.50
Price/Book (mrq): 1.15
Enterprise Value/Revenue (ttm)3: 1.31
Enterprise Value/EBITDA (ttm)6: 8.92
Financial Highlights  
Fiscal Year
Fiscal Year Ends: Dec 30
Most Recent Quarter (mrq): Mar 31, 2013
Profitability
Profit Margin (ttm): 7.51%
Operating Margin (ttm): 7.63%
Management Effectiveness
Return on Assets (ttm): 2.54%
Return on Equity (ttm): 6.27%
Income Statement
Revenue (ttm): 847.84M
Revenue Per Share (ttm): 7.27
Qtrly Revenue Growth (yoy): 23.40%
Gross Profit (ttm): 118.36M
EBITDA (ttm)6: 123.98M
Net Income Avl to Common (ttm): 63.69M
Diluted EPS (ttm): 0.52
Qtrly Earnings Growth (yoy): 145.50%
Balance Sheet
Total Cash (mrq): 462.11M
Total Cash Per Share (mrq): 3.91
Total Debt (mrq): 300.15M
Total Debt/Equity (mrq): 26.07
Current Ratio (mrq): 7.89
Book Value Per Share (mrq): 9.32
Cash Flow Statement
Operating Cash Flow (ttm): 104.25M
Levered Free Cash Flow (ttm): 25.81M
 
View Financials
Income Statement - Balance Sheet - Cash Flow
 
 
 

Trading Information  
Stock Price History
Beta: 2.85
52-Week Change3: 22.48%
S&P500 52-Week Change3: 20.66%
52-Week High (Feb 15, 2013)3: 14.87
52-Week Low (Jul 24, 2012)3: 7.47
50-Day Moving Average3: 11.70
200-Day Moving Average3: 12.49
Share Statistics
Avg Vol (3 month)3: 1,834,000
Avg Vol (10 day)3: 1,429,290
Shares Outstanding5: 118.10M
Float: 116.19M
% Held by Insiders1: 0.31%
% Held by Institutions1: 91.50%
Shares Short (as of Jun 14, 2013)3: 16.13M
Short Ratio (as of Jun 14, 2013)3: 9.50
Short % of Float (as of Jun 14, 2013)3: 19.20%
Shares Short (prior month)3: 14.99M
Dividends & Splits
Forward Annual Dividend Rate4: N/A
Forward Annual Dividend Yield4: N/A
Trailing Annual Dividend Yield3: N/A
Trailing Annual Dividend Yield3: N/A
5 Year Average Dividend Yield4: N/A
Payout Ratio4: N/A
Dividend Date3: N/A
Ex-Dividend Date4: N/A
Last Split Factor (new per old)2: 3:2
Last Split Date3: Jan 4, 1999
See Key Statistics Help for definitions of terms used.
Abbreviation Guide: K = Thousands; M = Millions; B = Billions
mrq = Most Recent Quarter (as of Mar 31, 2013) 
ttm = Trailing Twelve Months (as of Mar 31, 2013) 
yoy = Year Over Year (as of Mar 31, 2013) 
lfy = Last Fiscal Year (as of Dec 31, 2012) 
fye = Fiscal Year Ending
1 Data provided by Thomson Reuters
2 Data provided by EDGAR Online
3 Data derived from multiple sources or calculated by Yahoo! Finance
4 Data provided by Morningstar, Inc.
5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
6 EBITDA is calculated by Capital IQ using methodology that may differ from that used by a company in its reporting

Currency in USD.

ITS SELLING AT QUITE A REASONABLE PRICE WITH A RELATIVELY LOW MARKET CAPITALIZATION.  THE RUSSIANS (NORILSK NICKEL) HAVE SOLD BACK THEIR 50% STAKE IN THE COMPANY AND NO LONGER OWN IT!

WE NEED TO SEE MORE 5 AND 10% HOLDERS. HEDGE FUNDS AND LARGE INSTITUTIONAL TRADERS SHOULD PROBABLY ADD POSITIONS TO THEIR PORTFOLIOS ON THIS HUGE PRECIOUS METAL PRICE DOWNDRAFT.

Major Direct Holders (Forms 3 & 4)
Holder Shares Reported
MCALLISTER FRANCIS R 1,330,800 May 19, 2013
WING GREGORY A 236,896 May 12, 2013
STARK JOHN 157,999 Nov 15, 2012
ACKERMAN TERRELL I 129,977 May 9, 2013
SHIELL KEVIN G 48,157 May 9, 2013
 
 
 

Top Institutional Holders
Holder Shares % Out Value* Reported
Vanguard Group, Inc. (The) 6,929,667 5.87 89,600,594 Mar 31, 2013
BlackRock Fund Advisors 5,900,840 5.00 76,297,861 Mar 31, 2013
Altrinsic Global Advisors, LLC 5,277,263 4.47 68,235,010 Mar 31, 2013
State Street Corporation 3,834,560 3.25 49,580,860 Mar 31, 2013
Fisher Investments, Inc. 3,730,355 3.16 48,233,490 Mar 31, 2013
Carlson Capital. L.P. 3,309,515 2.80 42,792,028 Mar 31, 2013
Dimensional Fund Advisors LP 3,255,999 2.76 42,100,067 Mar 31, 2013
BlackRock Institutional Trust Company, N.A. 3,236,983 2.74 41,854,190 Mar 31, 2013
Sun Valley Gold LLC 3,204,132 2.71 41,429,426 Mar 31, 2013
Platinum Investment Management Ltd 16,149,640 13.68 208,814,845 Mar 31, 2013

Top Mutual Fund Holders
Holder Shares % Out Value* Reported
iShares Core S&P Smallcap ETF 2,075,949 1.76 24,890,628 May 31, 2013
SPDR (R) Ser Tr-SPDR (R) S&P (R) Metals & Mining ETF 1,819,197 1.54 21,812,172 May 31, 2013
BlackRock Global Allocation Fund 1,803,664 1.53 24,277,317 Jan 31, 2013
iShares Russell 2000 Index Fund 1,755,056 1.49 21,043,121 May 31, 2013
Vanguard Small-Cap Index Fund 1,667,445 1.41 21,560,063 Mar 31, 2013
Vanguard Total Stock Market Index Fund 1,595,471 1.35 20,629,440 Mar 31, 2013
Rainier Small/Midcap Equity Portfolio 1,397,680 1.18 18,072,002 Mar 31, 2013
Vanguard Small-Cap Growth Index Fund 1,395,012 1.18 18,037,505 Mar 31, 2013
Invesco Gold & Precious Metals Fund 1,296,233 1.10 16,760,292 Mar 31, 2013
Price (T.Rowe) Small-Cap Value Fund 1,174,200 0.99 15,182,406 Mar 31, 2013

View Transactions for Insiders & Institutional Holders

Value shown is computed using the security’s price on the report date given.

Currency in USD.

LOW RISK, HIGH UPSIDE

BE SURE TO CHECK OUT LAST EDITION:
THE NEXT BIG TRADE IDEA™: $CRAY VS. $AAPL – 7/6/13


COMMENTARY & NOTES

“IN THE SHORT TERM, THE MARKET IS LIKE A VOTING MACHINE. IN THE LONG TERM IT IS A WEIGHING MACHINE.”

THANK YOU TO ALL OF THE NEW SUBSCRIBERS AND BE SURE TO FORWARD THIS TO A FRIEND. HTTP://WWW.TINYURL.COM/TNBTI

THE NEXT BIG TRADE IDEA™: http://sTks.co/pIcs


THE 25K MODEL PORTFOLIO™ 
KEY POSITION ADDITIONS & CHANGES:

NO OTHER CHARTS OR SNAPSHOTS INCLUDED

John Chalekson
E-mail: [email protected]
THE NEXT BIG TRADE IDEA™ http://www.tinyurl.com/tnbti
Featured: /financial-markets/
LinkedIn: http://www.linkedin.com/pub/john-chalekson/52/357/653/

This email and any files transmitted with it are confidential and intended solely for the use of the individual or entity to whom they are addressed.  If you have received this email in error, please notify the system manager. This message contains confidential information and is intended only for the individual named.  If you are not the named addressee, you should not disseminate, distribute or copy this email.  Please notify the sender immediately by email if you have received this email by mistake and delete this email from your system.  If you are not the intended recipient, you are notified that disclosing, copying, distributing or taking any action in reliance on the contents of this information is strictly prohibited.

***
FEEDBACK? WE LOVE TO HEAR YOUR THOUGHTS AND OPINIONS!
http://clicktotweet.com/2b9lF
***
SIGN UP $10 PER EDITION VALUE: http://www.tinyurl.com/tnbti
‘EFFICIENTLY ALLOCATING INTELLECTUAL CAPITAL’
***


THE 25K MODEL PORTFOLIO™ 
NOV. 2012 – JULY 4 2013 

+324%
 

Follow on Twitter    Friend on Facebook    Forward to Friend
http://www.tinyurl.com/tnbti
http://www.linkedin.com/pub/john-chalekson/52/357/653/

Copyright © 2013 http://www.linkedin.com/pub/john-chalekson/52/357/653/, All rights reserved.


COPYRIGHT 2013 —  PLATOSCAVE CAPITAL LLC 

This email and any files transmitted with it are confidential and intended solely for the use of the individual or entity to whom they are addressed.  If you have received this email in error, please notify the system manager. This message contains confidential information and is intended only for the individual named.  If you are not the named addressee, you should not disseminate, distribute or copy this email.  Please notify the sender immediately by email if you have received this email by mistake and delete this email from your system.  If you are not the intended recipient, you are notified that disclosing, copying, distributing or taking any action in reliance on the contents of this information is strictly prohibited.

Disclaimer and Safe Harbor Statement 

JOHN CHALEKSON  and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “JOHN CHALEKSON” or “we” or “us” or “our”). JOHN CHALEKSON publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. JOHN CHALEKSON does not undertake any due diligence or investigation of the Information it obtains or publishes. You should not consider the Information published by JOHN CHALEKSON  to be a true, accurate, complete or reliable. The Profiled Companies actual results and financial condition may differ materially and be completely different than that published or described in the Information. The Information is not an offer or solicitation to buy or sell securities of the Profiled Companies. You should not consider the Information to be a recommendation or indication as to when you should buy or sell securities or if you should buy or sell securities of the Profiled Companies. JOHN CHALEKSON  and its officers, directors, owners and employees are not licensed as brokers, broker dealers, market makers, investment bankers, investment advisors, analysts or underwriters. You should not consider the Information when making an investment decision of whether to buy or sell securities of any Profiled Company on JOHN CHALEKSON  and you should consult with and request that your investment advisor or attorney verify any information you rely upon in making an investment decision. You should consult your financial and legal advisers before purchasing or selling the securities of any Profiled Company. Affiliates, officers, directors and employees of JOHN CHALEKSON  may own or may purchase shares of the Profiled Companies and may sell their securities at times when JOHN CHALEKSON  publishes Information on the Profiled Company including when investors purchase the securities of the Profiled Companies.
 
JOHN CHALEKSON  will not advise you prior to buying or selling the securities of the Profiled Companies does not and the Information should not be considered when making a decision to buy or sell securities of the Profiled Companies. The Information is not a solicitation or recommendation to buy, sell or hold securities and does not provide reliable information or analysis of the financial position of the Profiled Companies. All statements in the Information are subject to change without notice and are not reliable. JOHN CHALEKSON  is not liable for any investment decisions by its readers. Readers should independently investigate and fully understand all risks before investing in any Profiled Company.
 
 
The owners, associates, officers, directors and/or employees and/or principals of JOHN CHALEKSON  may have stock positions in the Profiled Companies obtained from purchases in the open market or in private transactions. JOHN CHALEKSON  will liquidate any securities of the Profiled Companies at its discretion without notification to any party including you even it has made published positive Information about a Profiled Company. By reviewing JOHN CHALEKSON ‘s website you accept these terms and conditions. 
 
Any investment in the Profiled Companies involves a high degree of risk and involves risks and uncertainties, which may result in investors losing all of their invested capital. Past performance does not guarantee future results.
  
The information contained herein contains “forward-looking statements,” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are based upon expectations, estimates and projections at the time the statements are made and involve risks and uncertainties that could cause actual events to differ materially from those anticipated. Forward-looking statements may be identified thorough the use of words such as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should, or might occur. Any statements that express or involve predictions, expectations, beliefs, plans, projections, objectives, goals or future events or performance may be forward-looking statements. Factors that could cause actual results to differ materially include but are not limited to adverse economic conditions, intense competition, lack of meaningful research results, inadequate capital, termination of contracts or agreements, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other key personnel, and other risks detailed in public information including but not limited to reports filed with the Securities and Exchange Commission.  Securities and Exchange Commission, at http://www.sec.gov . 
 
Buying and Selling of Shares: 
JOHN CHALEKSON  may sell any shares of the Profiled Companies for less than target prices set forth in the Information and may profit by selling their securities while investors are purchasing during the same time JOHN CHALEKSON  publishes the Information. 
 
If at anytime you wish to be removed from our list simply unsubscribe in any of the previous emails sent to you. 
 
17 (B) Disclaimer 
 
JOHN CHALEKSON  electronically disseminates information on its website, in newsletters, featured reports, spam compliant double-opt in email communications or otherwise pertaining to Profiled Companies. 
 
Your use of the Information is at your own risk. JOHN CHALEKSON  disclaims, expressly and impliedly, all warranties of any kind, including whether the Information is accurate or reliable or free of errors. By reading the Information, you hereby agree to indemnify and hold JOHN CHALEKSON  harmless from any liability for any claimed direct, indirect, incidental, punitive, or consequential damages pertaining to the Information.
  
The Information is presented only as a brief “snapshot” of the Profiled Company and should only be used, at most, and if at all, as a method of obtaining the names of penny stocks and a starting point for you to conduct a thorough investigation of the Profiled Company and its securities and to consult your financial, legal or other advisor(s) and avail yourself to the filings and information that may be accessed at www.sec.gov . or other electronic medium, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed; (c) obtaining and reviewing publicly available information contained in commonly known search engines such as Google and Yahoo! Finance; and (e) consulting investment guides at www.sec.gov and www.finra.com pertaining to the risks of investing. Readers must evaluate and bear all the risks associated with the Information, including reliance on its accuracy, completeness or usefulness. In all instances, you should conduct due diligence and its own review of the Profiled Companies and its securities. 
 
 
Copyright © 2013 http://www.linkedin.com/pub/john-chalekson/52/357/653/, All rights reserved.
LONG/SHORT EQUITY TRADING, WHERE TECHNICALS MEET FUNDAMENTALS.
PRICE IS WHAT YOU PAY, VALUE IS WHAT YOU GET
http://www.tinyurl.com/tnbti
unsubscribe from this list    update subscription preferences



Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!


Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST

Order by Phone at 866-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST

Order by Phone at 866-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST


Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation.

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)

Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen!

Nascent Iodine - Promotes detoxification, mental focus and thyroid health.

Smart Meter Cover -  Reduces Smart Meter radiation by 96%! (See Video).

Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.